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Nanostructured neural interfaces, comprising nanotubes or nanowires, have the potential to overcome
the present hurdles of achieving stable communication with neuronal networks for long periods of time.
This would have a strong impact on brain research. However, little information is available on the brain
response to implanted high-aspect-ratio nanoparticles, which share morphological similarities with
asbestos ﬁbres. Here, we investigated the glial response and neuronal loss in the rat brain after im-
plantation of biostable and structurally controlled nanowires of different lengths for a period up to one
year post-surgery. Our results show that, as for lung and abdominal tissue, the brain is subject to a
sustained, local inﬂammation when biostable and high-aspect-ratio nanoparticles of 5 mm or longer are
present in the brain tissue. In addition, a signiﬁcant loss of neurons was observed adjacent to the 10 mm
nanowires after one year. Notably, the inﬂammatory response was restricted to a narrow zone around the
nanowires and did not escalate between 12 weeks and one year. Furthermore, 2 mm nanowires did not
cause signiﬁcant inﬂammatory response nor signiﬁcant loss of neurons nearby. The present results
provide key information for the design of future neural implants based on nanomaterials.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Achieving long-term monitoring and interaction with neuronal
circuits of the central nervous system (CNS) in conscious in-
dividuals will have great impact in neuroscience, both for research
and clinical applications [1e4]. However, current neural interfaces
usually show a decline in performance over time and typically do
not provide stable communication with individual neurons. It is
commonly assumed that these shortcomings are due to an encap-
sulating inﬂammatory tissue response to the implant and conse-
quent displacement/loss of neurons nearby [5e8]. Notably, this
occurs despite using nontoxic materials. There is accumulating
evidence indicating that microforces between the brain, which
constantly exhibits movements, and neural interfaces, which84, Sweden. Tel.: þ46 (0)46
ics, Lund University, Box 118,
N. Prinz), Cecilia.Eriksson_
Ltd. This is an open access article utypically exhibit a poormechanical compliancewith the tissue, play
an important part in fuelling the inﬂammatory tissue response and
contribute to the instability of neural recordings [9e12].
A promising approach to locally improve the mechanical
compliance of implants is to use ﬂexible nanomaterials, such as
nanorods or carbon nanotubes (CNTs), on the surface of the neural
interfaces. Surfaces coated with CNTs have been reported to
improve the electrical properties and lower the evoked inﬂam-
matory tissue response towards neural interfaces, both in vivo and
in vitro [13,14]. Nanowire-modiﬁed substrates have been shown to
promote neuronal growth and limit the proliferation of glial cells
in vitro [15e17]. Furthermore, successful in vivo neural recordings
have recently been achieved using nanowire-based electrodes [18].
In order to achieve long-term communication with the brain,
these nanostructures need to be biostable. However, concerns have
been raised about using biostable, long, and high-aspect-ratio
nanoparticles (such as nanowires and CNTs) in the brain. In ro-
dent abdominal tissue and lungs, it has been shown that biostable
nanotubes, nanowires and nanorods of lengths comparable to the
size of immune cells, can induce frustrated phagocytosis, resulting
in a chronic inﬂammationwhich escalates over time, comparable tonder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Table 1
Experimental setup; included and excluded animals listed (n ¼ one unilateral im-
plantation site). Total group number in bold.
Naïve Stab
wound
SW-control Control 2 mm
HfOx
5 mm
HfOx
10 mm
HfOx
Groups at 12 weeks 18 8 8 24 26 24 24
12 week included 18 8 8 20 20 18 16
12 week excludeda 0 0 0 4 6 6 8
Groups at one year 20 e e 20 20 20 20
One year included 18 e e 16 11 15 15
One year excludedb 2 e e 4 9 5 5
a At 12 weeks, animals were excluded for meeting predetermined histological
exclusion criteria's.
b At one year, animals were excluded either for meeting ethical guideline
exclusion criteria's (tumours) or predetermined histological exclusion criteria's.
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aspect-ratio nanoparticles detached from implanted neural in-
terfaces could pose a similar risk and give rise to an escalating in-
ﬂammatory response as seen in asbestosis. At present, little is
known concerning the brain tissue response after long-term
exposure to biostable nanoparticles having morphological fea-
tures similar to asbestos ﬁbres.
To clarify the long-term risks involved in using nanostructured
neural interfaces for stable communication with brain cells, we
here examine the chronic brain tissue response to implantation of
biostable nanorods of equal diameter but different lengths.
Epitaxially grown nanowires were used as a model particle for
high-aspect-ratio nanorods since their dimensions can be
controlled precisely [22]. The glial response and neuronal survival
after implantation of biostable nanowires of three different lengths
in the rat brain were evaluated after up to one year implantation
time, which corresponds to half of the animal's lifespan.
The results show that nanowire length has a signiﬁcant inﬂu-
ence on the inﬂammatory tissue response as well as on neuronal
survival. Whereas no signiﬁcant increase in glial response or loss
of neurons was found for 2 mm long nanowires, the longer
nanowires studied (5 and 10 mm) caused a persistent, but not
escalating, glial response. Furthermore, for the 10 mmnanowires, a
signiﬁcant loss of neurons could be seen at one year post
implantation.
2. Methods
2.1. Nanowire growth and coating
Metal organic vapour phase epitaxy (Aix 200/4, Aixtron, Germany) was used to
grow gallium phosphide (GaP) nanowires from 40 nm gold aerosol particles
randomly distributed on a (111)B GaP substrate (Girmet Ltd, Moscow, Russia) at an
average density of 1/mm2, as previously described [22,23]. The temperature for
nanowire growth was 470 C and wire growth was initiated by supplying Ga(CH3)3
in addition to PH3. Precursor molar fractions were 4.3  106 and 8.5  102 for
Ga(CH3)3 and PH3, respectively, in a hydrogen carrier gas ﬂow of 6 L/min. The growth
was conducted under low pressure (10 kPa). The growth duration was adjusted to
produce nanowires of different lengths (2 ± 0.2 mm, 5 ± 0.2 mm and 10 mm ± 0.5 mm).
The nanowire length was characterized by scanning electron microscope (SEM)
imaging.
In order to obtain nanowires with a stable and inert surface chemistry, the GaP
nanowires were coated with a 20 nm layer of hafnium oxide (HfOx) using atomic
layer deposition (Savannah-100 system, Cambridge NanoTech Inc., USA), resulting in
a ﬁnal nanowire diameter of 80 nm ± 5 nm (±10 nm for the 10 mm long nanowires)
which was characterized using SEM imaging (Fig. 1). Titanium is widely used as a
biomaterial; hafnium belongs to the same group (IVB) as titanium in the periodic
table of elements and has been shown to display similar biocompatible traits as
titanium [24,25]. In addition, hafnium oxide has been shown to be biocompatible
even in a nano conﬁguration [26]. The substrates were cleaned with in an oxygen
plasma chamber (Plasma Preen, Plasmatic Systems Inc., USA) and can therefore be
expected to carry hydroxyl groups at the surface [27]. The nanowires were subse-
quently broken off from the substrate using ultra sonication and suspended in
Hank's balanced salt solution (HBSS) to a ﬁnal concentration of 70,000 nanowires/
mL. For further detailed description, see Eriksson Linsmeier et al., 2009 [28].Fig. 1. SEM images of nanowires. Representative SEM images of vertical GaP nanowires coate
the length and diameter of the nanowires. Stage tilt 20 . Scale bars: 1 mm (a), and 200 nm2.2. Animals
Approval for the animal experiments described below was obtained from the
Lund/Malm€o local ethical committee on animal experiments. A total of 116 female
SpragueeDawley (SD) rats (Taconic, Denmark) were used in this study. All rats
received food andwater ad libitum andwere kept in a 12-h dayenight cycle. The rats
weighed approximately 225 g at the beginning of the experiment. The rats followed
a normal weight curve after surgery and up to the experimental end point.
For the 12 week time point, seven different experimental groups were used.
Three groups received bilateral injections of 2, 5 or 10 mm long HfOx-coated nano-
wires in HBSS. One group received bilateral control vehicle-injections (HBSS only).
One group was kept naïve (no surgical procedures). An additional set of animals
received stabwounds (SW) in one hemisphere and control-injections (HBSS only) in
the contralateral hemisphere (SW-control). For the one-year time point, ﬁve
different experimental groups were used. Three groups received bilateral injections
of 2, 5 or 10 mm long HfOx-coated nanowires in HBSS, and one group received
bilateral control-injections (HBSS only). One group was kept naïve (no surgical
procedures).
We found spontaneous tumours in eight out of 60 animals (13.33%) in the one
year group (rats approximately 425 days old). Upon tumour detection, these animals
were immediately terminated and excluded from the study. A summary of the an-
imal group history is shown in Table 1. The prevalence of the tumours was
distributed evenly over all groups, including the naïve group (no surgical pro-
cedures). The occurrence of spontaneous age-related tumours in SD rats has pre-
viously been well documented with a reported tumour incidence of 57e58% in
female SD rats kept until day 540 or allowed to live out their lifespan [29,30]. Due to
the prevalence of tumours in our naïve and control rats and the vast literature
demonstrating the incidence of spontaneous tumours in aged rats, the tumours
observed in our study were therefore most likely age-related, and not linked to the
presence of nanowires in the brain [29e32].
2.3. Surgery
The rats were deeply anaesthetized by intraperitoneal (i.p.) injections of Fen-
tanyl (0.3 mg/kg body weight) and Domitor vet (metedetomidin hydrochloride,
0.3 mg/kg body weight). The surgical procedures have been described in detail
previously [28]. In short, the anaesthetized animals were prepared for surgery, i.e.
their heads were shaved and they were placed in a stereotactic frame (KOPF in-
struments, USA) set under a stereomicroscope (Leica Microsystems, Germany). The
scalp was disinfected using 70% ethanol solution and local anaesthetic, 0.25% Mar-
caine (Bupivacaine, 0.33 mg/kg body weight) in sterile water, was administered. To
expose the skull a 2 cm midline incision was made. Tissue attached to the skull wasd with HfOx, at low (a) and high (b) magniﬁcation. SEM images were used to determine
(b).
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were drilled at 1.0 mm anterior and 2.5 mm lateral to bregma under stereotactic
control. The dura mater was incised and deﬂected using ﬁne forceps. Bilateral ste-
reotactic injections at the above-mentioned coordinates were made using a 2 mL
Hamilton syringe with a glass microcapillary (tip ø ~ 130 mm) attached. The sus-
pensionwas injected into the striatum at two different depths; i) 5 mm (1 mL) and ii)
4 mm (1 mL); in total 2 mL/hemisphere over a total time of 2  2 min. The amount of
nanowires injected corresponds to an estimation of the number of nanowires that
could detach from a future nanostructured neural interface. Stab wounds were
performed in an identical manner. After injections or stab wound, the skin was
closed using surgical clips. The surgeries for the different groups took place in
different sessions. In order to conﬁrm that the nanowires were still individually
suspended in the HBSS and had not assembled into larger aggregates, a drop of the
suspension containing nanowires was ejected from the syringe onto a microscope
slide and examined using a Nikon eclipse 80i microscope, before and after each
injection series.
The animals received subcutaneous injections of Temgesic (buprenorphine,
50 mg/kg body weight) to reduce postoperative pain, as well as an antidote to the
anaesthesia (Antisedan, atipamezole hydrochloride, 0.5 mg/kg body weight), and
were awakened under supervision.
2.4. Histology
The animals were killed by an i.p. overdose of pentobarbital and transcardially
perfused with 200 mL of ice-cold saline solution (sodium chloride 0.9% in distilled
water) followed by 125mL of ice-cold 4% paraformaldehyde (PFA) in 0.1 M phosphate
buffer (pH 7.4). The brains were carefully removed and post-ﬁxed in 4% PFA over-
night (4 C). In addition, lymph nodes, liver, heart and vessels from all experimental
groups (12 weeks and one year) (n ¼ 24) were dissected and post-ﬁxed in 4% PFA.
The tissues were cryoprotected in 25% sucrose solution until equilibrated and
were subsequently attached to the sectioning block using Tissue Tek O.C.T. com-
pound (Sakura Finetek, USA). Coronal serial sections of the brains were cut (6 series)
at 10 mm thickness onto Super Frost® plus slides (Menzel-Gl€aser, Germany) using a
cryostat (Microm, Germany). The markers used to visualize activated microglia and
macrophages (CD68/ED1), astrocytes (glial ﬁbrillary acidic protein (GFAP)), and
neuronal nuclei (NeuN) are summarized in Table 2. All sections were counterstained
using the cell nuclei marker 40 ,6-diamidino-2-phenylindole (DAPI).
The lymph nodes, liver, heart and vessels were sectioned in the same manner
as mentioned above, at 10 mm thickness and labelled with ED1 and DAPI. They
were subsequently screened for presence of nanowires using a Nikon eclipse 80i
microscope and a laser scanning confocal microscope (Zeiss LSM 510). Nanowires
scatter confocal laser light and can therefore be visualized using the laser-
reﬂection mode.
Tissue sections were hydrated in phosphate buffered saline (PBS) and blocked
with 5% normal goat serum and 0.25% Triton X-100 in PBS (blocking solution). In-
cubation with primary antibodies (in blocking solution) was made at room tem-
perature (RT) overnight. Sections were subsequently rinsed in PBS followed by
incubation with DAPI, goat anti-rabbit IgG Alexa 594 and goat anti-mouse IgG Alexa
488 (in blocking solution) in the dark (RT) for 2 h (Table 2). Sections were rinsed and
coverslipped using PVA-DABCO (polyvinyl alcohol, Fluka/SigmaeAldrich,
Switzerland).
Prior to NeuN staining an antigen retrieval method was performed. In short,
after hydration, the sections selected for NeuN staining were immersed in a 10 mM
sodium citrate buffer (0.05% Tween 20, pH 6) and microwaved for 3  5 min at
500 W. Tris-buffer (SigmaeAldrich, Germany) was used instead of PBS for all steps
and Triton X-100 was omitted from the blocking solution, otherwise all steps were
made according to the staining protocol above.Table 2
Summary of primary antibodies, secondary antibodies and nucleic acid stain.
Name Characteristics Host Working
dilution
Source
ED1
(CD68)
Activated
microglia/macrophages
Mouse 1:250 Cat. Nr.
MCA341R,
AbD Serotec
GFAP Glial ﬁbrillary acidic protein Rabbit 1:5000 Cat. Nr. Z0334,
Dako
NeuN Neuronal nuclei,
neuronal marker
Mouse 1:100 Cat. Nr.
MAB377,
Millipore
Alexa
594
Goat anti-rabbit IgG (H þ L) Goat 1:500 Cat. Nr. A11005,
Invitrogen
Alexa
488
Goat anti-mouse IgG (H þ L) Goat 1:500 Cat. Nr. A11001,
Invitrogen
DAPI Nucleic Acid Stain
(40 ,6-diamidino-2-phenylindole)
1:1000 Cat. Nr. D3571,
Invitrogen2.5. Image acquisition and analysis for quantitative assessment
In order to quantitatively evaluate the density of neurons and activation state of
glial cells in deﬁned regions of interest (ROIs) in relation to the injection site, we
quantiﬁed the binding of selected markers to cell speciﬁc proteins/antigens in the
tissue. In short, the sections were screened to detect the location of the scar where
the ED1- and GFAP-positive area was seen at its maximum. At this location, pho-
tographs of the ﬂuorescence of the ED1- and GFAP-positive cells and cell nuclei
(DAPI) were taken at each injection site, using a DS-2MV digital camera (Nikon,
Japan) mounted on a Nikon eclipse 80i microscope with a 10 objective. Image
capture and analysis were performed using the NIS-Elements 3.1 software (Nikon
Instruments, Japan). The adjacent brain sections were stained using NeuN, GFAP and
DAPI and photographs of the injection sites were taken.
The quantiﬁcation analysis was based on a previously described method [28]. In
short, rectangular shaped ROIs, inner and outer ROIs (100  800 mm and
300  800 mm, respectively), were centred on the injection tract (Supplementary
Fig. 1). The different cell quantiﬁcations were made by measuring the proportion
of immunoreactive area (for ED1 and GFAP) and the number of cells (for NeuN and
DAPI) in the total screened area for each marker and injection site for all experi-
mental groups [28]. Due to variability in the binding speciﬁcity of ED1 and GFAP to
their respective antigen, thresholds were set for each individual image at a ﬁxed
ratio of the mean background intensity for each marker. The thresholds were set to
ensure that only positively stained antigens were quantiﬁed, whereas the nonspe-
ciﬁc background staining was not. The threshold for the signal to background ratio
was set to 5.5 for ED1 immunoﬂuorescence and to 4.5 for GFAP immunoﬂuores-
cence. The fraction of the area above this threshold in each ROI was quantiﬁed.
Neuronal nuclei were counted manually by matching NeuN-positive cells with a co-
stained DAPI-positive nucleus within the ROIs. Cell nuclei were countedmanually by
counting the number of DAPI-positive nuclei (above ø 3 mm to avoid counting debris/
artefacts) within the ROI.
Confocal images of the scar were photographed with a laser scanning
confocal microscope (Zeiss LSM 510) using a 63 oil-immersion objective (N.A.
1.4) and the ZEN software (Zeiss). Nanowires were visualized using the laser-
reﬂection mode.2.6. Statistical analyses
Kruskal Wallis with Dunn's multiple comparison test was used to compare
the experimental groups. Wilcoxon matched-pairs signed rank test was used
when paired comparisons of two experimental groups were performed (SW vs.
SW-control). p-values < 0.05 (*) were considered signiﬁcant. All values are pre-
sented as median values, together with 25 and 75 percentiles, as well as, minimum
and maximum values. All analyses were performed using the GraphPad Prism 6.0
software (GraphPad Software Inc., USA).3. Results
To determine the effects of the length of biostable high-aspect-
ratio nanowires on the evoked inﬂammatory tissue response, we
injected nanowires of three different lengths (2, 5 and 10 mm) into
the rat striatum. The animals were killed and perfused either after
12 weeks or one year. In order to assess the degree of reactive
astrocytosis and the evoked inﬂammatory response, brain sections
from all groups were stained for ED1- (microglial cells and mac-
rophages) and GFAP-positive cells (astrocytes). To assess the
neuronal survival and the number of total cell nuclei in the scar
area, NeuN (neuronal nuclei) and DAPI (cell nuclei) were used. The
different markers were quantiﬁed in two regions of interest (ROIs)
surrounding the injection tract (see method for detailed experi-
mental protocol).3.1. General observations
At both time points, areas positive for ED1 and GFAP were
signiﬁcantly larger for control and experimental groups, when
compared to the naïve group (inner ROI) (Supplementary Table 1).
The neuronal and cell nuclei density (inner ROI) in control and
experimental groups was signiﬁcantly lower as compared to the
naïve group at both time points (Supplementary Table 1).
Excluding brain tissue, no nanowires were detected in addi-
tionally dissected and investigated tissues, i.e. in the lymph nodes,
liver, heart and vessels, in any of the experimental groups.
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In order to investigate the effect of the control, (i.e. vehicle so-
lution, Hank's balanced salt solution (HBSS)), we performed bilat-
eral surgery on eight animals; stab wound (SW) and a stab wound
with control injection of HBSS (SW-control) in opposing hemi-
spheres, respectively. No signiﬁcant difference in ED1-positive area,
neuronal density or cell nuclei density (inner or outer ROI) could be
found when comparing the responses in the two groups (SW vs.
SW-control) after 12 weeks. However, GFAP-positive area was
signiﬁcantly higher (p ¼ 0.023) in the inner ROI for the SW group
(mean 17.4% ± 2.3%) as compared to SW-control (mean
10.9% ± 1.3%) (Fig. 2). These results indicate that HBSS may lower
the astrocytic inﬂammatory response in the brain towards the stab
wound caused by the injection needle.
3.3. Effect of nanowire length on the brain tissue response after 12
weeks
We injected nanowires of three different lengths (2, 5 and
10 mm) and assessed the brain tissue response and cell density 12
weeks after the injections. Representative ﬂuorescence microscopy
images of the scar tissue area after injections of control solution and
nanowires of different lengths are shown in Fig. 3.Fig. 2. Analysis of SW and SW-control after 12 weeks. (aed) Quantiﬁcation in the inner RO
nuclei density (d) at 12 weeks for stab wound (SW) and stab wound with injection of vehicle
the 25 and 75 percentiles, and the whiskers show the minimum and maximum values. W
statistical differences (*p < 0.05, **p < 0.01, ***p < 0.001).3.3.1. Microglia/macrophage response
A signiﬁcant increase in ED1-positive area, in the inner ROI, was
found for the group receiving 10 mm long nanowires compared to
both the control group (p¼ 0.0074) and to the group receiving 2 mm
long nanowires (p ¼ 0.018), with a mean percentage of ﬂuorescent
area of 3.75% ± 0.78% (for 10 mm nanowires), 1.01% ± 0.13% (for
control), and 1.11% ± 0.15% (for 2 mm nanowires) (Fig. 4). In the
outer ROI, no signiﬁcant difference in ED1-positive area was found
when comparing the groups (data not shown). Moreover, the
overall immunoreactive area for ED1 in the outer ROI was close to
zero in all groups, indicating that the microglial and macrophage
activity is largely limited to the inner ROI 12 weeks after
implantation.
3.3.2. Astrocytic reactivity
In the inner ROI, we observed a signiﬁcant increase in GFAP-
positive area in the group receiving 10 mm long nanowires
compared to the control group (p¼ 0.035),with ameanpercentage of
ﬂuorescent area of 18.3%± 2.3% and 9.34%± 1.3%, respectively (Fig. 4).
In the outer ROI, therewas a signiﬁcant increase inGFAP-positive area
for the group receiving 5 mm long nanowires compared to the control
group (p ¼ 0.049), with a mean percentage of ﬂuorescent area of
5.75% ± 1.1% and 2.30% ± 0.38%, respectively (Fig. 4). Furthermore, a
trend towards an increase in GFAP-positive area in the outer ROI wasI (0e50 mm) of ED1-positive area (a), GFAP-positive area (b), NeuN density (c), and cell
solution, HBSS (SW-control). The boxes correspond to median values with indication of
ilcoxon matched-pairs signed rank test was used and the horizontal lines indicate
Fig. 3. In vivo tissue response after 12 weeks. Representative ﬂuorescent images of the tissue response to injections of control and 2, 5 and 10 mm long HfOx (hafnium oxide) -coated
nanowires at 12 weeks. ED1-positive cells (green), GFAP-positive cells (red), and cell nuclei (blue) and merge. Scale bars: 100 mm.
L. G€allentoft et al. / Biomaterials 42 (2015) 172e183176seen for the group receiving 10 mm long nanowires (4.45% ± 0.52%)
compared to the control group (p ¼ 0.056) (Fig. 4).
3.3.3. Neuronal density
There was no signiﬁcant difference in the number of neuronal
nuclei (NeuN), in the inner (Fig. 4) or outer ROI (data not shown)
between the different groups 12 weeks after the injections. This
suggests that no nanowire-induced neurotoxic effect was present
at this time point.3.3.4. Cellular density
A signiﬁcant increase in the number of cell nuclei (DAPI) was
found in the group receiving 10 mm long nanowires compared to
the control group (p ¼ 0.0071), with a mean nuclei density of
0.00265 ± 7.7e-005 mm2 and 0.00227 ± 4.7e-005 mm2, respec-
tively (Fig. 4). This corresponds to a 16.7% increase in cell nuclei in
the 10 mm nanowire-injected group compared to control, which
may be explained by the increase of ED1 and GFAP- positive cells in
this group.
Fig. 4. Inﬂammatory response and neuronal density after 12 weeks. (aed) Quantiﬁcation in the inner ROI (0e50 mm) of ED1-positive area (a), GFAP-positive area (b), NeuN density
(c), and cell nuclei density (d) at 12 weeks for nanowire- injected animals and control group. (e) Quantiﬁcation in the outer ROI (50e150 mm) of GFAP-positive area at 12 weeks for
nanowire-injected animals and control group. Hf corresponds to hafnium oxide coated nanowires. The boxes correspond to median values with indication of the 25 and 75
percentiles, and the whiskers show the minimum and maximum values. Kruskal Wallis with Dunn's multiple comparison test was used and the horizontal lines indicate statistical
differences (*p < 0.05, **p < 0.01, ***p < 0.001).
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year
Representative ﬂuorescence microscopy images of the scar tis-
sue area after injections of control solution and nanowires of
different lengths one year after surgery are shown in Fig. 5.
3.4.1. Microglia/macrophage response
In the inner ROI a signiﬁcant increase in ED1-positive area was
found in the group receiving 10 mm (mean area of 2.82% ± 0.59%,p ¼ 0.0003) and 5 mm long nanowires (mean area 1.65% ± 0.32%,
p ¼ 0.029) compared to the control group (mean area
0.690% ± 0.081%) (Fig. 6). In the outer ROI, however, there was no
signiﬁcantdifference inED1-positiveareacomparing thegroups (data
not shown) and the overall immunoreactive area for ED1 in this ROI
was close to zero in all groups, comparable to theﬁndings at12weeks.
3.4.2. Astrocytic reactivity
In the inner ROI, there was no signiﬁcant difference in GFAP-
positive area between any of the groups (Fig. 6). In the outer ROI,
Fig. 5. In vivo tissue response after one year. Representative ﬂuorescent images of the tissue response to injections of control and 2, 5 and 10 mm long HfOx (hafnium oxide) -coated
nanowires at one year. ED1-positive cells (green), GFAP-positive cells (red), and cell nuclei (blue) and merge. Scale bars: 100 mm.
L. G€allentoft et al. / Biomaterials 42 (2015) 172e183178however, a signiﬁcant increase of GFAP-positive area was found in
the group receiving 10 mm long nanowires (7.31% ± 1.1%) compared
to the group receiving 5 mm long nanowires (3.61% ± 0.46%)
(p ¼ 0.042) (Fig. 6).
3.4.3. Neuronal density
In the inner ROI, a signiﬁcant decrease in the neuronal nuclei
density was found in the group receiving 10 mm long nanowires(66.6e-005 ± 4.9e-005 mm2) compared to the control group
(88.0e-005 ± 5.2e-005 mm2) (p ¼ 0.032) (Fig. 6). This corresponds
to a 24.2% loss of neuronal nuclei in the 10 mm nanowire group
compared to control. In the outer ROI, however, no signiﬁcant dif-
ference in neuronal density was found when comparing the
different groups (data not shown). This ﬁnding suggests that the
reduction of neurons observed in the 10 mm group in the inner ROI,
Fig. 6. Inﬂammatory response and neuronal density after one year. (aed) Quantiﬁcation in the inner ROI (0e50 mm) of ED1-positive area (a), GFAP-positive area (b), NeuN density
(c), and cell nuclei density (d) at one year for nanowire-injected animals and control group. (eef) Quantiﬁcation in the outer ROI (50e150 mm) of GFAP-positive area (e) and NeuN
density (f) at one year for nanowire-injected animals and control group. Hf corresponds to hafnium oxide coated nanowires. The boxes correspond to median values with indication
of the 25 and 75 percentiles, and the whiskers show the minimum and maximum values. Kruskal Wallis with Dunn's multiple comparison test was used and the horizontal lines
indicate statistical differences (*p < 0.05, **p < 0.01, ***p < 0.001).
L. G€allentoft et al. / Biomaterials 42 (2015) 172e183 179was not due to a displacement of neurons from the inner ROI to the
outer ROI.
3.4.4. Cellular density
There was no signiﬁcant difference in the number of cell nuclei
when comparing the different groups one year after the injections
(Fig. 6).3.5. Confocal analysis of the nanowire distribution
At both time points, confocal examination of the groups
receiving nanowires showed that ED1-positive cells had engulfed
most of the 2 mm long nanowires. However, some of the 5 mm and
10 mm long nanowires could be seen free in the tissue, i.e. not
engulfed by any type of labelled cell, (Figs. 7e8). We also observed
L. G€allentoft et al. / Biomaterials 42 (2015) 172e183180nanowires lining blood vessel walls at both time points, free or
engulfed by ED1-positive cells (Figs. 7e8). Furthermore, in the
centre of the injection tract, small aggregations of co-localized ED1
and GFAP staining could be observed. These aggregates resembled
cell debris or cell aggregates, and the dominating majority con-
tained nanowires, see Fig. 9. However, they were regularly devoid
of DAPI-positive nuclei, suggesting that they were not viable cells.
The aggregates were mostly observed in the groups with longer
nanowires (5 and 10 mm) and were rarely found at the early time
point, i.e. at 12 weeks.4. Discussion
To assess possible risks involved in using future nanowire-
structured neural interfaces, we analyzed the tissue response
and neuronal survival after injection of non-degradable, high-
aspect-ratio nanoparticles into the brain, for a period corre-
sponding to approximately half the lifespan of a rat, i.e. one year.
Importantly, while the inﬂammatory tissue response depends on
the nanowire length, it did not escalate between 12 weeks and
one year. However, for the longest nanowires, the increased
microglial activation found at 12 weeks did persist for one year
and the neuronal density was reduced as compared to control
after one year.
At 12weeks post implantation, ED1 and GFAP immunoreactivity
was increased only in the 10 mm nanowire group as compared to
control. After one year, both 5 and 10 mm nanowires groups
exhibited an increase in ED1 immunoreactivity compared to the
control group. The increased ED1 response observed towards
longer nanowires might reﬂect a size dependent limit of the
phagocytic capacity of macrophages and microglial cells. Indeed,
the ﬁbre pathogenicity paradigm predicts that long, thin and bio-
stable ﬁbres will lead to frustrated phagocytosis and elicit a long
lasting/chronic inﬂammatory response. Such asbestos-like patho-
genicity has been observed after implantation of long CNTs in the
mice abdominal tissue [20]. More recently, the same group used
silver nanowires with narrow length distributions to investigate
the length threshold for asbestos-like pathogenicity in the lung and
the pleura, which was determined to be around 5e10 mm [21,33].
The present results are consistent with these ﬁndings. The
observed cell debris/cell aggregates, containing 5 and 10 mm long
nanowires (Fig. 9), could be compared to granulomas, which sup-
ports the hypothesis that the phagocytosis of the longer nanowires
cannot be completed normally. It may be speculated that longer
nanowires exert a higher strain force on the membrane of the
phagocytizing cells since these nanowires are close to the size of
the microglial cells [34]. This strain might impede the engulfment
of nanowires or lead to membrane deformation or even piercing of
the cell membrane during engulfment or migration, which could
lead to cell death.
In the present study, we found a higher number of 5 and
10 mm long nanowires that were free in the brain tissue (i.e. not
engulfed by any type of labelled cells) compared to 2 mm long
nanowires (which were almost always engulfed by ED1-positive
cells). This suggests that when unable to phagocytize long
nanowires, cells either undergo apoptosis without signalling toFig. 7. Confocal images 12 weeks after nanowire injection. Representative laser
scanning confocal microscopy images of the scar after injection of 2 (a), 5 (b), and
10 mm (c) long nanowires at 12 weeks. Free nanowires, not engulfed by any labelled
cell type, were observed in the scar area. ED1-positive cells (green), GFAP-positive cells
(red), cell nuclei (blue), nanowires (white), free nanowires (/), and blood vessels (*).
Scale bars: 30 mm.
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long nanowires.
Importantly, our results showed no indication of an escalation
of the inﬂammatory tissue response over time. However, the
neuronal density in the immediate vicinity of the injection tract
for the 10 mm nanowire-injected group was reduced as compared
to control, at the one year follow up, indicating that neurons in the
10 mm group are slowly dying over time. This might be related to
the increased glial response to 10 mm nanowires as compared to
shorter nanowires. It has been reported that activated glial cells
may continuously secret neurotoxic substances, which could
explain the neuronal cell loss one year post nanowire injection
[35e37].
The nanowires used in this study are non-degradable by
design and therefore cannot be cleared by phagocytic activity.
However, we observed nanowires lining blood vessel walls near
the injection site, both free and engulfed by ED1-positive cells
(Figs. 7e8). This may suggest a clearance mechanism by trans-
location, where ED1-positive cells migrate and transport nano-
wires to blood vessels in their vicinity. Similar observations have
been made several decades ago after injection of colloidal carbon
into the brain [38]. Our previous study, on short and biode-
gradable nanowires in the brain, also suggested a nanowire
clearance mechanism through the blood vessels [28]. It is known
that the CNS lacks conventional lymphatic drainage. Recent
studies have shown that the cerebrospinal ﬂuid drains mainly
from the subarachnoid space through the cribriform plate into
nasal lymphatics and to deep cervical lymph nodes, and inﬁl-
trating monocytes are also capable of migrating via the cribri-
form plate [39,40]. Drainage of interstitial ﬂuid and solutes, on
the other hand, has been suggested to mainly occur through the
basement membrane in the walls of capillaries, ultimately ending
up in the cervical lymph nodes [39]. Hence, it is possible that the
microglial cells and macrophages containing nanowires follow
these routes as well. In our case, no nanowires could be detected
in the dissected lymph nodes, suggesting that, either the injected
nanowires could not leave the brain, or that too small amounts of
nanowires were cleared out of the brain to be detected.
Vehicle injections of HBSS led to a smaller astrocytic reactivity
compared to stab wound without vehicle injection. This suggests
that HBSS may reduce the adverse effects caused by the stab
wound. Possible explanations for this could be that the injected
solution dilutes the concentration of inﬂammatory cytokines
locally, thereby, indirectly reducing the ensuing inﬂammatory
response at the injection site. Further studies are needed in order to
determine the mechanisms behind this observation.5. Conclusions
In conclusion, we show that the brain inﬂammatory response to
the implantation of biostable nanorods and the loss of nearby
neurons are strongly length dependent. The results indicate that,
similar to the lungs and abdomen, a persistent, albeit not esca-
lating, inﬂammatory response occurs in the brain when high-
aspect-ratio particles, with a length equal to or greater than the
size of immune cells, are present in the tissue. The obtained resultsFig. 8. Confocal images one year after nanowire injection. Representative laser scan-
ning confocal microscopy images of the scar after injection of 2 (a), 5 (b), and 10 mm (c)
long nanowires at one year. Free nanowires, not engulfed by any labelled cell type,
were observed in the scar area for the longer nanowires (5 and 10 mm). ED1-positive
cells (green), GFAP-positive cells (red), cell nuclei (blue), nanowires (white), free
nanowires (/), and blood vessels (*). Scale bars: 30 mm.
Fig. 9. Confocal image of an aggregate at one year after nanowire injection. Laser
scanning confocal microscopy image of the scar area after injection of 5 mm long
nanowires at one year showing the aggregates of cell debris or cells observed in the
tissue at one year. ED1-positive cells (green), GFAP-positive cells (red), cell nuclei
(blue), and nanowires (white). Scale bars: 10 mm.
L. G€allentoft et al. / Biomaterials 42 (2015) 172e183182stress the importance of using nanorods that are shorter than the
size of brain immune cells, when modifying the surface of neural
interfaces in order to improve their performance.
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